Coherus Biosciences Inc [NASDAQ: CHRS] jumped around 0.03 points on Wednesday, while shares priced at $2.48 at the close of the session, up 1.22%. Compared to the average trading volume of 5.93M shares, CHRS reached a trading volume of 3853741 in the most recent trading
Coherus Biosciences Inc [NASDAQ: CHRS] slipped around -0.13 points on Thursday, while shares priced at $2.17 at the close of the session, down -5.65%. The company report on March 13, 2024 at 4:01 PM that Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and
Coherus Biosciences Inc [NASDAQ: CHRS] closed the trading session at $2.21. The company report on March 5, 2024 at 4:01 PM that Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024. A replay of the webcast will be available
Coherus Biosciences Inc [NASDAQ: CHRS] surged by $0.3 during the normal trading session on while it closed the day at $2.32. The company report on February 5, 2024 at 8:00 AM that Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP. – Estimated balance of
Coherus Biosciences Inc [NASDAQ: CHRS] stock went on an upward path that rose over 0.43% on Tuesday, amounting to a one-week price decrease of less than -3.75%. The company report on January 22, 2024 at 1:15 AM that Coherus Announces Agreement to Divest Ophthalmology Franchise
© 2024, Powered by Smart TechOne
